A phase I/Ii study of 131i mIBG in chemo-resistant neuroblastoma. the United Kingdom Children's Cancer Study Group (UKCCSG)
Lewis, I.J.; Lashford, L.S.; Fielding, S.; Flower, M.A.; Ackery, D.; Kemshead, J.
Progress in Clinical and Biological Research 366: 463-469
1991
ISSN/ISBN: 0361-7742 PMID: 2068161 Document Number: 376195
Document emailed within 1 workday
Related Documents
George, R.E.; Kenyon, R.M.; McGuckin, A.G.; Malcolm, A.J.; Pearson, A.D.; Lunec, J. 1996: Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group Oncogene 12(7): 1583-1587Bernstein, I.D.; Evans, A.E.; Finklestein, J.; Klemperer, M.; Hittle, R.; Leikin, S.; Hammond, G.D. 1978: Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study Group Cancer Treatment Reports 62(8): 1201-1202
Stratton, J.F.; Buckley, C.H.; Lowe, D.; Ponder, B.A. 1999: Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group Journal of the National Cancer Institute 91(7): 626-628
Nitschke, R.; Starling, K.; Lui, V.K.; Pullen, J. 1981: Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: a Southwest Oncology Group Study Cancer Treatment Reports 65(11-12): 1105-1108
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213
Nomura, Y.; Abe, O.; Enomoto, K.; Fujiwara, K.; Tominaga, T.; Hayashi, K.; Uchino, J.; Takahashi, M.; Hayasaka, A.; Asaishi, K.; Okazaki, M.; Abe, R.; Kimishima, I.; Kajiwara, T.; Haga, S.; Shimizu, T.; Miyazaki, I.; Noguchi, M.; Yoshida, M.; Miura, S.; Taguchi, T.; Oota, J.; Sakai, K.; Kinoshita, H.; Tashiro, H. 1998: Phase i study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 553-561
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Liu, B.; Zhuang, H.; Servaes, S. 2013: Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 21-28
Yokoyama, A.; Nakai, Y.; Yoneda, S.; Kurita, Y.; Niitani, H.; Taguchi, T. 1996: A late phase Ii study of LY188011 (Gemcitabine hydrochloride) in patients with non-small-cell lung cancer. Gemcitabine Cooperative Study Group B for Late Phase Ii Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(12): 1681-1688
Pitts, N.B.; Evans, D.J. 1997: The dental caries experience of 5-year-old children in the United Kingdom. Surveys coordinated by the British Association for the Study of Community Dentistry in 1995/96 Community Dental Health 14(1): 47-52
Eisenhauer, E.A.; Evans, W.K.; Raghavan, D.; Desmeules, M.J.; Murray, N.R.; Stuart-Harris, R.; Wilson, K.S. 1986: Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study Cancer Treatment Reports 70(8): 1029-1030
Alostad, A.H.; Steinke, D.T.; Schafheutle, E.I. 2018: International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain Pharmaceutical Medicine 32(1): 39-49
Sugihara, K.; Auther, C.; Mori, S.; Nishihira, T.; Matsumoto, T.; Kawachi, S.; Ishikawa, M.; Takahashi, M.; Nakajima, T.; Kosaki, G. 1990: Early phase Ii study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2405-2413
Wagener, D.J.; van Oosterom, A.T.; Mulder, J.H.; Somers, R.; Mouridsen, H.T.; Cortes Funes, H.; Thomas, D.; Sylvester, R. 1986: Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer Cancer Treatment Reports 70(5): 615-618
Covens, A.; O'Connell, G.; Rusthoven, J.; Mazurka, J. 1992: Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer European Journal of Gynaecological Oncology 13(2): 125-130
Taguchi, T.; Wakui, A.; Nabeya, K.; Kurihara, M.; Isono, K.; Kakegawa, T.; Ota, K. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(4): 483-488
Van Cutsem, E.; Blijham, G.H. 1999: Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group Seminars in Oncology 26(1 Suppl. 5): 13-20
Sasaki, T.; Ota, K.; Taguchi, T.; Ogawa, N.; Kurihara, M.; Akazawa, S.; Ogawa, M.; Tominaga, T.; Konishi, T.; Kumai, K. 1995: A randomized early phase Ii study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 521-529
Carpenter, J.T.; Raney, M.; Logan, T. 1986: Phase Ii evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(5): 679-680